Oskar Hansson
121 – 130 of 663
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Five biomarkers from one cerebrospinal fluid sample to stage Alzheimer’s disease
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer’s Disease
- Contribution to journal › Scientific review
-
Mark
Cerebrovascular disease is associated with Alzheimer's plasma biomarker concentrations in adults with Down syndrome
- Contribution to journal › Article
-
Mark
Diffusion tensor imaging along the perivascular space : the bias from crossing fibres
- Contribution to journal › Article
-
Mark
Diagnosis of Alzheimer's disease using plasma biomarkers adjusted to clinical probability
- Contribution to journal › Article
-
Mark
A clinical perspective on the revised criteria for diagnosis and staging of Alzheimer's disease
- Contribution to journal › Debate/Note/Editorial
-
Mark
Baseline Characteristics from Evoke and Evoke+ : Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer's Disease (P11-9.013)
- Contribution to journal › Published meeting abstract
-
Mark
Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
MRI-Derived AD Signature of Cortical Thinning and Plasma P-Tau217 for Predicting Alzheimer Dementia Among Community-Dwelling Older Adults
- Contribution to journal › Article
-
Mark
Revised criteria for the diagnosis and staging of Alzheimer’s disease
- Contribution to journal › Debate/Note/Editorial
